3.2 Therapeutic potential in obesity Although the incretin effects of GIPR undoubtedly play a crucial role in preventing postprandial glucose excursion, there is still intensive debate on whether the GIPR should be activated or inhibited for the treatment of obesity
Discussion 1) The clinical and pharmacological evaluations of Tirzepatide comprehensively detail its superior efficacy in metabolic regulation compared to selective GLP-1 receptor agonists, attributed to its unique dual agonism of both GIP and GLP-1 receptors
Navigating the compounded semaglutide landscape The market for compounded semaglutide has expanded significantly
It should not be self-administered
May-Jun 2006;33(5-6):533-540
For international patients who need evaluation for unexplained fatigue, muscle symptoms, or suspected metabolic disorders, Acibadem Internationals multidisciplinary specialists and JCI-accredited hospitals provide diagnosis and treatment planning tailored to the underlying condition